Asthma & COPD - SMi's sixth annual conference
Related Experiment Video
Updated: Jun 12, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
1Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. saloni.shah@thomsonreuters.com
Abstract:
SMi's sixth annual conference on Asthma & COPD, held in London, included topics covering new therapeutic developments in the field of asthma and COPD. This conference report highlights selected presentations on understanding these diseases; bronchodilators and corticosteroids, both of which remain a mainstay in asthma therapy; new developments in COPD therapy; PI3K inhibitors as a new treatment approach for asthma and COPD; and oligonucleotides, particularly DNAzyme therapy for asthma.
Related Concept Videos
Asthma III: Clinical Manifestations
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction
